Navigation Links
ImaginAb, Inc. and GE Imanet Sign Agreement to Provide Customized, Targeted PET Imaging Agents for Drug Research
Date:10/11/2010

et's capabilities and ImaginAb's rapidly growing pharmaceutical industry clientele."

About ImaginAb

Founded in 2007 by UCLA Faculty (Dr. Rob Reiter and Dr. Anna Wu), ImaginAb, Inc. is a biotechnology company specializing in the development of engineered antibody fragments for diagnostic imaging and novel therapeutic applications. The company has a significant pipeline of clinical products in development oriented towards unmet needs in cancer and immunology. ImaginAb is also developing a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT and optical imaging systems, and partners on a selective basis with biopharmaceutical companies with an interest in developing companion imaging agents for therapeutic antibody products.  For more information about ImaginAb, visit www.imaginab.com.

About GE Imanet

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.  The company's broad expertise in medical imaging and information technologies, medical diagnostics, drug discovery and performance solutions services help its customers to deliver better care to more people around the world at a lower cost.  Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE).  Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professional and their patients in more than 100 countries.  An integral part of GE Healthcare's Medical Diagnostics business, Imanet™ is a network of clinical PET centers conducting exploratory phase PET imaging studies to aid in the development of products for the pharmaceutical industry since 2001.  For more information about GE Healthcare, visit www.gehealthcare.com and 

SOURCE ImaginAb, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ImaginAb, Inc. and BZL Biologics, LLC Conclude Licensing Agreement for Imaging Rights to huJ591/Prostate-Specific Membrane Antigen (PSMA)
2. Johnson & Johnson and Crucell Reach Agreement on Intended Public Offer of Euro 24.75 per Ordinary Share of Crucell
3. IGEN AMENDS DISTRIBUTION AGREEMENT AND ANNOUNCES FIRST SPECTRUM BUILD-OUT
4. Tongjitang Chinese Medicines Company Enters into Share Transfer Agreement
5. Clinical Genomics Pty Ltd and The Garvan Institute of Medical Research Enter into Licensing Agreement
6. NeoStem Presented at NASDAQ MarketSite in New York to Discuss Entry Into Merger Agreement With Progenitor Cell Therapy
7. GeneLink Announces HelixLife Private Label Distribution Agreement
8. TOPICA Pharmaceuticals Announces Sublicensing Agreement for Tinea Indication
9. Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses
10. Drug Development in Arizona Gets Boost Following ASU-Quintiles Agreement
11. Dynamic Ventures Corporation enters into a long-term agreement that brings $50 million annual sales opportunity for wholly owned subsidiary EZ-Build.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 The consumption of compound fertilizers ... recession and high prices in 2008. However, the situation ... keeps on gaining momentum now. , To date, the ... than 100,000 thousand tonnes. No considerable growth was registered ... capacity rocketed during 2012-2013, registering 11% growth as against ...
(Date:3/27/2015)... , March 27, 2015 Working ... Free Hospital in London , Richmond Pharmacology ... a global Phase 3 study for an investigational RNAi therapeutic ... orphan disease affecting the nerves and heart. ... Detail Based at St Georges University of ...
(Date:3/26/2015)... PRC Clinical, a Silicon-Valley based contract ... executive appointments effective immediately. , Mike Catelani will assume ... of the Board of Directors. Daniel Head is appointed ... will assume the position of Senior Director of Clinical ... (COO), has been appointed to the position of President ...
(Date:3/26/2015)... Neogen Corporation (NASDAQ: NEOG ) announced today that ... 2015, which ended Feb. 28, increased 13% to $7,454,000, ... share in the current quarter were $0.20, compared to ... 17% over prior year to $24,142,000, or $0.65 per ... the same period a year ago. Revenues ...
Breaking Biology Technology:World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 3PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3Neogen reports 13% increase in net income 2Neogen reports 13% increase in net income 3Neogen reports 13% increase in net income 4Neogen reports 13% increase in net income 5Neogen reports 13% increase in net income 6Neogen reports 13% increase in net income 7Neogen reports 13% increase in net income 8
... TIKVA, Israel, December 4 Healthcare,Technologies Ltd. (NASDAQ: ... of its unaffiliated and voting shareholders (approximately 90%),voted ... At the meeting, the shareholders were asked to ... Biofuels, Inc, Mac,Bioventures Inc. and Gamida for Life ...
... 4 Biotest Pharmaceuticals,Corporation, a leading developer ... has completed the acquisition of the Nabi,Biopharmaceuticals ... for $185 million,in cash. Biotest Pharmaceuticals is ... the acquisition of the Nabi Biologics product ...
... Maxygen, Inc.,(Nasdaq: MAXY ), a biotechnology company ... today the license of its proprietary,dengue virus antigen ... sanofi-aventis Group., Under the terms of the ... of preclinical dengue antigens for development and,worldwide commercialization ...
Cached Biology Technology:Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction 2Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit 2Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit 3Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur 2Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur 3
(Date:3/18/2015)... CORAL SPRINGS, Florida , March 18, 2015 ... as well as businesses, new revolutionary smart wallets and apps ... rapid pace.  Companies currently entrenched in the mobile payment industry ... ), Alibaba Group Holding Ltd. (NYSE: BABA ), ... GOOG ) and Facebook Inc. (NASDAQ: ...
(Date:3/17/2015)... March 17, 2015  MecklerMedia Corporation (OTCQX: MECK) ... for service robots ever held in ... on May 11-13, 2015 at the Javits Convention ... the event include: Acorn Product Development; Axis NJ; ... Kinova Robotics; Littler; NewBotic Corporation; Neya Systems LLC; ...
(Date:3/12/2015)... WINSTON-SALEM, N.C. , March 12, 2015 ... afternoon at Brenner Children,s Hospital, part of Wake Forest ... an outreach initiative for the 2015 ACC Men,s Basketball ... taking pictures with them and getting their autographs. ... Wake Forest Baptist. It is the only children,s hospital ...
Breaking Biology News(10 mins):Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... and Building Media Inc. (BMI), a DuPont subsidiary, will ... help dramatically improve the energy efficiency of American homes ... 15 teams, appointed by the U.S. Department of Energy ... million for the initial 18 months to deliver innovative ...
... flu are common occurrences during pregnancy, and research has ... flu, viruses and other infections during pregnancy have about ... A new study out of Temple University examines what,s ... month in Schizophrenia Research , Temple University psychologist ...
... University researchers conducting zooarchaeological and archaeometric analyses of four ... Project in northeastern Ethiopia within walking distance of ... afarensis ) confirm that unusual marks on the ... in on findings reported in the Aug. 12 journal ...
Cached Biology News:NJIT to help lead public/private partnership to develop high-efficiency homes 2Immune responses during pregnancy linked to schizophrenia among offspring 2Immune responses during pregnancy linked to schizophrenia among offspring 3Animal bone markings show evidence that 'Lucy' species used stone tools, ate meat 2Animal bone markings show evidence that 'Lucy' species used stone tools, ate meat 3Animal bone markings show evidence that 'Lucy' species used stone tools, ate meat 4
...
...
Assay Diluent, 10 L...
... Clone/PAD: ZMD.474. Immunogen: Synthetic ... of the mouse junctophilin-3. Specificity: ... the junctophilin-3 protein. Reactivity: Mouse ... mouse hippocampus and heart tissues). ...
Biology Products: